- Lambert MP, Gernsheimer TB.(2017) . Clinical updates in adult immune thrombocytopenia. Blood 129:2829–35. doi: 10.1182/blood-2017-03-754119.
- Morodomi Y , Kanaji S , Won E , Ruggeri ZM , Kanaji T .(2020). Mechanisms of anti-GPlba antibody-induced thrombocytopenia, Blood; 135 (25): 2292-2301.
- Audia, S., Mahévas, M., Samson, M., Godeau, B., & Bonnotte, B. (2017). Pathogenesis of immune thrombocytopenia. Autoimmunity reviews, 16(6), 620-632.
- Chen L, Flies DB.(2013) . Molecular mechanisms of T cell co-stimulation and inhibition. Nat Rev Immunol 13:227–42. doi: 10.1038/nri3484 .
- Lim EL, Okkenhaug K.(2019) . Phosphoinositide 3-kinase delta is a regulatory T-cell target in cancer immunotherapy. Immunology (2019) 157:210–8. doi: 10.1111/ imm.13082 .
- Vernerova L, Spoutil F, Vlcek M, Krskova K, Penesova A, Meskova M, et al.(2016) . ACombination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case-Control Study. PloS One (2016) 11:e0153316. doi: 10.1371/journal.pone. 0153316.
- Wang, M. J., Yang, H. Y., Zhang, H., Zhou, X., Liu, R. P., & Mi, Y. Y. (2016). TNFAIP3 gene rs10499194 and rs13207033 polymorphisms decrease the risk of rheumatoid Oncotarget, 7(50), 82933.
- Terrell, D. R., Beebe, L. A., Vesely, S. K., Neas, B. R., Segal, J. B., & George, J. N. (2010). The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. American journal of hematology, 85(3), 174-180
- Rui, L., Schmitz, R., Ceribelli, M., & Staudt, L. M. (2011). Malignant pirates of the immune system. Nature Immunology, 12(10), 933-940.
- Huang, J., Yang, Y., Liang, Z., Kang, M., Kuang, Y., & Li, F. (2015). Association between the CD24 Ala57Val polymorphism and risk for multiple sclerosis and systemic lupus erythematosus: a meta-analysis. Scientific reports, 5(1), 9557.
- Abdaljabbar, H. N., Faraj, S. A., & AL-Rubae, A. M. (2020). Study of Immune Thrombocytopenia (ITP) in Iraqi children in Wasit Province. EurAsian Journal of BioSciences, 14(2).
- Taha, G. E. M., Ahmed, A. B., & Mabrouk, A. G. (2022). Chemokine 12 plasma level in pediatric patients with Immune Thrombocytopenic purpura and its relation to Disease Activity. Egyptian Journal of Medical Research, 3(2), 213-225.
- Diab, A. M., Abouamer, A. A., Motaleb, G. S. A., Eid, K. A., & Abdelnaiem, H. I. (2021). Prognostic evaluation of immune thrombocytopenia outcomes in Egyptian children: a retrospective single-center experience. Вопросы гематологии/онкологии и иммунопатологии в педиатрии, 20(3), 26-30.
- Ali, A., Zahad, S., Masoumeh, A., & Azar, A. (2008). Congenital malformations among live births at Arvand Hospital, Ahwaz, Iran-A prospective study. Pakistan Journal of Medical Sciences, 24(1), 33.
- Ariawati, K., & Setiyawan, I. M. K. (2019). Platelets level response after three days therapy in children with acute Immune Thrombocytopenic Purpura (ITP): a 10 years’ experience at the tertiary hospital. Bali Medical Journal, 8(3), 897-901.
- Mohammed, M. A., Ahmed, A. S., Zidan, A. A., & Abd EL-Hakam, A. M. (2022). Study of Clinical Features and Laboratory Findings in Children with Immune Thrombocytopenia. The Egyptian Journal of Hospital Medicine, 87(1), 2096-2100.
- AL-Zuhairy, S. H. (2013). Evaluation of prognostic factors in newly diagnosed childhood primary immune thrombocytopenia (ITP): a two-year prospective study at Al-Sadder Hospital, Missan Province. Med J Babylon, 10, 855-69.
- Ismail, A. M., Higazi, A. M., Nomeir, H. M., & Farag, N. M. (2021). IL-23/Th17 pathway and IL-17A gene polymorphism in Egyptian children with immune thrombocytopenic Italian Journal of Pediatrics, 47, 1-8.
- Mohammed, M. A., Ahmed, A. S., Zidan, A. A., & Abd EL-Hakam, A. M. (2022). Study of Clinical Features and Laboratory Findings in Children with Immune Thrombocytopenia. The Egyptian Journal of Hospital Medicine, 87(1), 2096-2100.
- El-hady, M. A., Mosallam, D. S., Anis, S. K., Mansour, B. S., & Yassa, M. E. (2021). Tumor necrosis factor-induced protein 3 gene polymorphism and the susceptibility to chronic primary immune thrombocytopenia in Egyptian children: a case-control study. Egyptian Journal of Medical Human Genetics, 22(1), 1-9.
- Fida, N. M., Hamed, E., Jaber, S., Al Najjar, S., Al Amawi, D., Al Siny, F., & Alharthy, B. (2021). Presentation and Management of Primary Immune Thrombocytopenia in Children at the King Abdulaziz University Hospital, Jeddah, Saudi Arabia: A Retrospective Study. Journal of King Abdulaziz University-Medical Sciences, 28(1), 1-9.
- El-hady, M. A., Mosallam, D. S., Anis, S. K., Mansour, B. S., & Yassa, M. E. (2021). Tumor necrosis factor-induced protein 3 gene polymorphism and the susceptibility to chronic primary immune thrombocytopenia in Egyptian children: a case-control study. Egyptian Journal of Medical Human Genetics, 22(1), 1-9.
- Ismail, A. M., Higazi, A. M., Nomeir, H. M., & Farag, N. M. (2021). IL-23/Th17 pathway and IL-17A gene polymorphism in Egyptian children with immune thrombocytopenic purpura. Italian Journal of Pediatrics, 47, 1-8.
- Zitek, T., Weber, L., Pinzon, D., & Warren, N. (2022). Assessment and management of immune thrombocytopenia (ITP) in the emergency department: current perspectives. Open Access Emergency Medicine, 25-34.
- Terrell, D. R., Neunert, C. E., Cooper, N., Heitink-Pollé, K. M., Kruse, C., Imbach, P., ... & Ghanima, W. (2020). Immune thrombocytopenia (ITP): current limitations in patient management. Medicina, 56(12), 667.
|